Bristol Myers Squibb (CELG-RI) Minority Interest (2009 - 2026)

Bristol Myers Squibb (CELG-RI) reported Minority Interest of $34.0 million for Q1 2026, down 42.37% year-over-year from $59.0 million in Q1 2025, and up 3.03% quarter-over-quarter from $33.0 million in Q4 2025.

Bristol Myers Squibb (CELG-RI) Minority Interest (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (CELG-RI) has 18 years of Minority Interest data on file, last reported at $34.0 million in Q1 2026.

  • Minority Interest for Q1 2026 came in at $34.0 million, down 42.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.0 million (down 42.37% YoY), and the FY2025 annual result was $33.0 million, down 37.74% from the prior year.
  • Minority Interest climbed to $34.0 million in Q1 2026 per CELG-RI's latest filing, from $33.0 million in the prior quarter.
  • Over five years, Minority Interest peaked at $65.0 million in Q1 2022 and troughed at $33.0 million in Q4 2025.
  • A 5-year average of $55.0 million and a median of $57.0 million in 2022 frame the typical range for Minority Interest.
  • The sharpest annual moves came in 2025 and 2026: Minority Interest climbed 1.72% in 2025, then plunged 42.37% in 2026.
  • A 5-year view of Minority Interest shows it stood at $57.0 million in 2022, then fell by 3.51% to $55.0 million in 2023, then dropped by 3.64% to $53.0 million in 2024, then plunged by 37.74% to $33.0 million in 2025, then rose by 3.03% to $34.0 million in 2026.
  • Business Quant data shows CELG-RI's Minority Interest at $34.0 million in Q1 2026, $33.0 million in Q4 2025, and $48.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 34.00 Mn
Dec 31, 2025 33.00 Mn
Sep 30, 2025 48.00 Mn
Jun 30, 2025 54.00 Mn
Mar 31, 2025 59.00 Mn
Dec 31, 2024 53.00 Mn
Sep 30, 2024 58.00 Mn
Jun 30, 2024 54.00 Mn
Mar 31, 2024 58.00 Mn
Dec 31, 2023 55.00 Mn
Sep 30, 2023 64.00 Mn
Jun 30, 2023 57.00 Mn
Mar 31, 2023 62.00 Mn
Dec 31, 2022 57.00 Mn
Sep 30, 2022 63.00 Mn
Jun 30, 2022 61.00 Mn
Mar 31, 2022 65.00 Mn
Dec 31, 2021 60.00 Mn
Sep 30, 2021 71.00 Mn
Jun 30, 2021 66.00 Mn